Cited by 3Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsNeuropeptides and Animal Physiology

Atrial natriuretic peptide, copeptin and adrenomedullin levels in polycystic ovary syndrome: a case-control study

Frøssing, Signe, Nylander, Malin, Aziz, Mubeena, Skouby, Sven O., Kistorp, Caroline, Faber, Jens·2017·Gynecological Endocrinology

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) defined by the Rotterdam criteria does not take into account the unhealthy metabolic profile of the syndrome with increased insulin resistance (IR) and overweight favoring development of type 2 diabetes, hypertension and cardiovascular disease (CVD). We assess three vasoactive peptides associated with CVD in women with PCOS. METHOD: Plasma levels of mid-regional pro-atrial natriuretic peptide (MR-proANP), copeptin and mid-regional pro-adrenomedullin (MR-proADM) were measured in 98 PCOS patients and 46 age- and BMI-matched healthy women. RESULTS: We found no difference in levels of MR-proANP, copeptin and MR-proADM between the PCOS and control group. Multiple regression analyses on a combined group of PCOS and control subjects demonstrated an inverse correlation between MR-proANP and IR (measured by fasting C-peptide) and a positive correlations between copeptin and IR as well as MR-proADM and BMI. We found no association between peptide levels and different Rotterdam phenotypes. CONCLUSION: Plasma concentrations of MR-proANP, copeptin and MR-proADM were not increased in PCOS compared to age- and BMI-matched controls. Thus, these peptides cannot be used to detect increased risk of CVD in a young PCOS cohort.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/09513590.2016.1202915

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The relatively low endogenous testosterone levels in women with PCOS compared with men do not seem to have any major influence on MR-proANP levels.

    “Based on these findings, the relatively low endogenous testosterone levels in women with PCOS compared with men do not seem to have any major influence on MR-proANP levels.”
  • In a previous cross-sectional study on 98 PCOS women, log2 MR-proANP and heart rate were significantly negatively correlated (β = −0.02, s.e. 0.004, r 0.43, P < 0.001).

    “From a previous cross-sectional study on 98 PCOS women (38), we were able to extract data on MR-proANP and heart rate, and could reproduce the significant negative correlation, between log2 MR-proANP and heart rate (β = −0.02 (s.e. 0.004), r 0.43, P < 0.001) (unpublished data).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 30 · Cited by 3

Authors
Frøssing, S., Nylander, M., Aziz, M., Skouby, S. O., Kistorp, C., & Faber, J.
Affiliations
  • University of Copenhagen (DK)
  • Herlev Hospital (DK)
Corresponding author
Frøssing, Signe
Venue
Gynecological Endocrinology
Published
2016-07-16
Volume
33
Issue
1
Pages
30-33
ISSN
  • 0951-3590 (ISSN-L)
  • 1473-0766
OpenAlex
W2473220193
Cited by
3
References
30
Citations by year
2022: 1 · 2020: 1 · 2018: 1
FWCI
0.44
Type
journal article
Language
en
Open access
closed
Locations
  • Gynecological Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
polycystic ovary syndrome, atrial natriuretic peptide, copeptin, adrenomedullin, vasoactive peptides, insulin resistance, cardiovascular risk, body mass index, Rotterdam criteria, cardiovascular disease
MeSH terms
Adolescent, Adult, Female, Glycopeptides, Humans, Atrial Natriuretic Factor, Polycystic Ovary Syndrome, Case-Control Studies, Adrenomedullin, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review